Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Japanese encephalitis virus (JEV) envelope glycoprotein, or E protein, is a structural protein critical for viral infectivity. It mediates both cellular attachment and membrane fusion during viral entry into host cells and is the primary target of neutralizing antibodies. The E protein is a class II fusion protein with three distinct domains, and undergoes conformational changes to facilitate membrane fusion. It is also glycosylated, which can affect its interaction with cellular receptors. As a major antigenic determinant, the E protein is a key component of JEV vaccines.
Neutralization of viral infectivity; prevention of viral entry
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Japanese encephalitis virus E glycoprotein (None).